AAAAAA

   
Results: 1-9 |
Results: 9
Assessment of equivalence on multiple endpoints
Authors: Quan, H Bolognese, J Yuan, WY
Citation: H. Quan et al., Assessment of equivalence on multiple endpoints, STAT MED, 20(21), 2001, pp. 3159-3173
Thermoreversible hydrogels XI: Effect of salt on the swelling properties of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels
Authors: Lee, WF Yuan, WY
Citation: Wf. Lee et Wy. Yuan, Thermoreversible hydrogels XI: Effect of salt on the swelling properties of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels, J APPL POLY, 79(9), 2001, pp. 1675-1684
Thermoreversible hydrogels XIII: Synthesis and swelling behaviors of [N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate-co-N,N-dimethyl(acrylamido propyl) ammonium propane sulfonate] copolymeric hydrogels
Authors: Lee, WF Yuan, WY
Citation: Wf. Lee et Wy. Yuan, Thermoreversible hydrogels XIII: Synthesis and swelling behaviors of [N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate-co-N,N-dimethyl(acrylamido propyl) ammonium propane sulfonate] copolymeric hydrogels, J POLYM R, 7(1), 2000, pp. 29-40
Thermoreversible hydrogels X: Synthesis and swelling behavior of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels
Authors: Lee, WF Yuan, WY
Citation: Wf. Lee et Wy. Yuan, Thermoreversible hydrogels X: Synthesis and swelling behavior of the (N-isopropylacrylamide-co-sodium 2-acrylamido-2-methylpropyl sulfonate) copolymeric hydrogels, J APPL POLY, 77(8), 2000, pp. 1760-1768
The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials
Authors: Morrison, BW Fricke, J Brown, J Yuan, WY Kotey, P Mehlisch, D
Citation: Bw. Morrison et al., The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials, J AM DENT A, 131(12), 2000, pp. 1729-1737
Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain
Authors: Gottesdiener, K Mehlisch, DR Huntington, M Yuan, WY Brown, P Gertz, B Mills, S
Citation: K. Gottesdiener et al., Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain, CLIN THER, 21(8), 1999, pp. 1301-1312
Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib inpost-dental surgery pain: A randomized, controlled trial
Authors: Morrison, BW Christensen, S Yuan, WY Brown, J Amlani, S Seidenberg, B
Citation: Bw. Morrison et al., Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib inpost-dental surgery pain: A randomized, controlled trial, CLIN THER, 21(6), 1999, pp. 943-953
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
Authors: Ehrich, EW Dallob, A De Lepeleire, I Van Hecken, A Riendeau, D Yuan, WY Porras, A Wittreich, J Seibold, JR De Schepper, P Mehlisch, DR Gertz, BJ
Citation: Ew. Ehrich et al., Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model, CLIN PHARM, 65(3), 1999, pp. 336-347
Introduction of multi-alien chromatins carrying different powdery mildew-resistant genes from rye and Haynaldia villosa into wheat genome
Authors: Yuan, WY Tomita, M Sun, SC Yasumuro, Y
Citation: Wy. Yuan et al., Introduction of multi-alien chromatins carrying different powdery mildew-resistant genes from rye and Haynaldia villosa into wheat genome, GENE GEN SY, 73(6), 1998, pp. 377-384
Risultati: 1-9 |